Turn Therapeutics (TTRX) EBITDA (2024 - 2026)
Turn Therapeutics (TTRX) EBITDA from Sep 30, 2024 to Mar 31, 2026. The TTM Turn Therapeutics (TTRX) EBITDA is -$3.87M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Turn Therapeutics (TTRX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +193.94% |
| All Time | +28.03% |
Annual EBITDA change of Turn Therapeutics (TTRX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$970K | -83.30% |
| 2025 | -$5.81M | +232.00% |
| 2024 | -$1.75M | N/A |